Latest Avoro Capital Advisors LLC Stock Portfolio
$8.57Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Avoro Capital Advisors LLC and it’s 13F Hedge Fund Stock Holdings
Avoro Capital Advisors LLC is a hedge fund based in NEW YORK, NY. On 10-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $7.8 Billions. In it's latest 13F Holdings report, Avoro Capital Advisors LLC reported an equity portfolio of $8.6 Billions as of 31 Mar, 2024.
The top stock holdings of Avoro Capital Advisors LLC are UTHR, APLS, ASND. The fund has invested 7.7% of it's portfolio in UNITED THERAPEUTICS CORP and 7.6% of portfolio in APELLIS PHARMACEUTICALS INC.
The fund managers got completely rid off MIRATI THERAPEUTICS INC (MRTX), CYMABAY THERAPEUTICS INC (CBAY) and STRUCTURE THERAPEUTICS INC stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), SPDR SERIES TRUST - S&P BIOTECH (BIL) and KRYSTAL BIOTECH INC (KRYS). Avoro Capital Advisors LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), ALPINE IMMUNE SCIENCES INC (ALPN) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to ARROWHEAD PHARMACEUTICALS INC (ARWR), TAYSHA GENE THERAPIES INC (TSHA) and TOURMALINE BIO INC.
The top stock holdings of Avoro Capital Advisors LLC are UTHR, APLS, ASND. The fund has invested 7.7% of it's portfolio in UNITED THERAPEUTICS CORP and 7.6% of portfolio in APELLIS PHARMACEUTICALS INC.
The fund managers got completely rid off MIRATI THERAPEUTICS INC (MRTX), CYMABAY THERAPEUTICS INC (CBAY) and STRUCTURE THERAPEUTICS INC stocks. They significantly reduced their stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), SPDR SERIES TRUST - S&P BIOTECH (BIL) and KRYSTAL BIOTECH INC (KRYS). Avoro Capital Advisors LLC opened new stock positions in VIKING THERAPEUTICS INC (VKTX), ALPINE IMMUNE SCIENCES INC (ALPN) and VERA THERAPEUTICS INC (VERA). The fund showed a lot of confidence in some stocks as they added substantially to ARROWHEAD PHARMACEUTICALS INC (ARWR), TAYSHA GENE THERAPIES INC (TSHA) and TOURMALINE BIO INC.
New Buys
| Ticker | $ Bought |
|---|---|
| VIKING THERAPEUTICS INC | 294,380,000 |
| ALPINE IMMUNE SCIENCES INC | 228,921,000 |
| VERA THERAPEUTICS INC | 227,027,000 |
| MACROGENICS INC | 90,528,000 |
| AUTOLUS THERAPEUTICS PLC | 78,765,400 |
| OCULAR THERAPEUTIX INC | 65,055,300 |
| VAXCYTE INC | 39,278,200 |
| CG ONCOLOGY INC | 30,730,000 |
New stocks bought by Avoro Capital Advisors LLC
Additions
| Ticker | % Inc. |
|---|---|
| ARROWHEAD PHARMACEUTICALS INC | 657 |
| TAYSHA GENE THERAPIES INC | 328 |
| TOURMALINE BIO INC | 155 |
| ULTRAGENYX PHARMACEUTICAL INC | 137 |
| AVIDITY BIOSCIENCES INC | 132 |
| SOLENO THERAPEUTICS INC | 107 |
| IOVANCE BIOTHERAPEUTICS INC | 74.63 |
| MARINUS PHARMACEUTICALS INC | 31.45 |
Additions to existing portfolio by Avoro Capital Advisors LLC
Reductions
| Ticker | % Reduced |
|---|---|
| ALNYLAM PHARMACEUTICALS INC | -73.00 |
| SPDR SERIES TRUST - S&P BIOTECH | -3.25 |
| KRYSTAL BIOTECH INC | -0.39 |
Avoro Capital Advisors LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| CYMABAY THERAPEUTICS INC | -262,444,000 |
| MIRATI THERAPEUTICS INC | -287,102,000 |
| STRUCTURE THERAPEUTICS INC | -95,106,700 |
| FENNEC PHARMACEUTICALS INC | -13,464,000 |
| IMMUNOGEN INC | -25,943,800 |
| NUVALENT INC | -13,166,800 |
| KARUNA THERAPEUTICS INC | -39,563,800 |
Avoro Capital Advisors LLC got rid off the above stocks
Current Stock Holdings of Avoro Capital Advisors LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AADI | AADI BIOSCIENCES INC | 0.08 | 2,849,400 | 6,667,600 | UNCHANGED | 0.00 | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 0.07 | 416,666 | 5,891,660 | NEW | ||
| AGLE | SPYRE THERAPEUTICS INC | 0.81 | 1,839,140 | 69,758,500 | UNCHANGED | 0.00 | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 0.52 | 300,000 | 44,835,000 | REDUCED | -73.00 | |
| ALPN | ALPINE IMMUNE SCIENCES INC | 2.67 | 5,775,000 | 228,921,000 | NEW | ||
| APLS | APELLIS PHARMACEUTICALS INC | 7.62 | 11,111,100 | 653,111,000 | UNCHANGED | 0.00 | |
| ARGX | ARGENX SE | 5.69 | 1,238,470 | 487,609,000 | ADDED | 0.32 | |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 2.85 | 8,555,560 | 244,689,000 | ADDED | 657 | |
| ASND | ASCENDIS PHARMA | 6.99 | 3,966,670 | 599,641,000 | ADDED | 5.62 | |
| AUTL | AUTOLUS THERAPEUTICS PLC | 0.92 | 12,345,700 | 78,765,400 | NEW | ||
| BCRX | BIOCRYST PHARMACEUTICALS INC | 0.77 | 13,050,000 | 66,294,000 | UNCHANGED | 0.00 | |
| BIL | SPDR SERIES TRUST - S&P BIOTECH | 4.76 | 4,300,000 | 408,027,000 | REDUCED | -3.25 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4.45 | 4,365,000 | 381,239,000 | ADDED | 1.51 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CERE | CEREVEL THERAPEUTICS HLDNG | 3.72 | 7,555,560 | 319,373,000 | UNCHANGED | 0.00 | |
| CRSP | CRISPR THERAPEUTICS AG | 0.33 | 419,580 | 28,598,600 | NEW | ||
| FENC | FENNEC PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FOLD | AMICUS THERAPEUTICS INC | 3.77 | 27,400,000 | 322,772,000 | UNCHANGED | 0.00 | |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.37 | 4,535,000 | 31,971,800 | UNCHANGED | 0.00 | |
| IMGN | IMMUNOGEN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 2.02 | 11,700,000 | 173,394,000 | ADDED | 74.63 | |
| ITCI | INTRA-CELLULAR THERAPIES INC | 2.00 | 2,475,000 | 171,270,000 | ADDED | 9.73 | |
| KRTX | KARUNA THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KRYS | KRYSTAL BIOTECH INC | 5.30 | 2,555,560 | 454,710,000 | REDUCED | -0.39 | |
| KURA | KURA ONCOLOGY INC | 0.96 | 3,850,000 | 82,120,500 | ADDED | 29.19 | |
| KYMR | KYMERA THERAPEUTICS INC | 1.82 | 3,888,890 | 156,333,000 | ADDED | 3.02 | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 6.06 | 1,944,440 | 519,244,000 | ADDED | 2.94 | |
| MGNX | MACROGENICS INC | 1.06 | 6,150,000 | 90,528,000 | NEW | ||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 1.51 | 2,580,000 | 129,593,000 | UNCHANGED | 0.00 | |
| MNKD | MANNKIND CORP | 0.48 | 9,000,000 | 40,770,000 | UNCHANGED | 0.00 | |
| MRNS | MARINUS PHARMACEUTICALS INC | 0.44 | 4,140,610 | 37,431,100 | ADDED | 31.45 | |
| MRTX | MIRATI THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MRUS | MERUS N V | 0.47 | 888,888 | 40,026,600 | UNCHANGED | 0.00 | |
| NUVL | NUVALENT INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| OCUL | OCULAR THERAPEUTIX INC | 0.76 | 7,148,940 | 65,055,300 | NEW | ||
| PCVX | VAXCYTE INC | 0.46 | 575,000 | 39,278,200 | NEW | ||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.45 | 830,000 | 38,752,700 | ADDED | 137 | |
| RCKT | ROCKET PHARMACEUTICALS INC | 0.40 | 1,260,900 | 33,968,600 | UNCHANGED | 0.00 | |
| RNA | AVIDITY BIOSCIENCES INC | 1.73 | 5,825,000 | 148,654,000 | ADDED | 132 | |
| ROIV | ROIVANT SCIENCES LTD | 0.57 | 4,651,160 | 49,023,200 | UNCHANGED | 0.00 | |
| SLNO | SOLENO THERAPEUTICS INC | 0.81 | 1,625,000 | 69,550,000 | ADDED | 107 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1.17 | 4,222,220 | 100,489,000 | UNCHANGED | 0.00 | |
| SRPT | SAREPTA THERAPEUTICS INC | 6.56 | 4,344,440 | 562,432,000 | UNCHANGED | 0.00 | |
| TSHA | TAYSHA GENE THERAPIES INC | 0.62 | 18,650,000 | 53,525,500 | ADDED | 328 | |
| UTHR | UNITED THERAPEUTICS CORP | 7.66 | 2,858,890 | 656,744,000 | UNCHANGED | 0.00 | |
| VERA | VERA THERAPEUTICS INC | 2.65 | 5,265,000 | 227,027,000 | NEW | ||
| VKTX | VIKING THERAPEUTICS INC | 3.43 | 3,590,000 | 294,380,000 | NEW | ||
| VRCA | VERRICA PHARMACEUTICALS INC | 0.28 | 4,000,000 | 23,680,000 | UNCHANGED | 0.00 | |
| XENE | XENON PHARMACEUTICALS INC | 2.85 | 5,666,670 | 243,950,000 | UNCHANGED | 0.00 | |
| TOURMALINE BIO INC | 0.59 | 2,222,220 | 50,888,900 | ADDED | 155 | ||
| CG ONCOLOGY INC | 0.36 | 700,000 | 30,730,000 | NEW | |||
| KYVERNA THERAPEUTICS INC | 0.14 | 475,000 | 11,799,000 | NEW | |||
| STRUCTURE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |